(Sharecast News) - National Grid: Berenberg upgrades to buy with a target price of 1,100p.
Hiscox: Berenberg reiterates hold with a target price of 973p.
ITV: Berenberg reiterates hold with a target price of 117p.
SIG: Canaccord reiterates hold with a target price of 45p.
Quixant: Canaccord reiterates buy with a target price of 200p.
ITV: JP Morgan reiterates overweight with a target price of 170p.
Tritax Big Box: Barclays reiterates equal weight with a target price of 205p.
UDG Healthcare: Barclays reiterates overweight with a target price of 975p.
Compass Group: Deutsche Bank reiterates buy with a target price of 1720p.
CVS: Liberum reiterates hold with a target price of 2,200p.
AstraZeneca: Liberum reiterates buy with a target price of 9,220p.
Gateley: Peel Hunt reiterates add with a target price of 200p.
Melrose: Peel Hunt reiterates buy with a target price of 300p.
Prudential: Credit Suisse reiterates outperform with a target price of 1,750p.
Next: Numis reiterates add with a target price of 7,200p.
Melrose: Numis reiterates add with a target price of 205p.
Astrazeneca (AZN)
Prudential (PRU)
SIG (SHI)
Gateley Holdings (GTLY)
CVS Group (CVSG)
National Grid (NG.)
Melrose (MRO)
Tritax Big Box (BBOX)
Next (NXT)
Compass Group (CPG)
ITV (ITV)
Hiscox (HSX)3 May 2024 12:17
CORRECT: Angle shares up on assay development deal with AstraZeneca
(Correcting company name in headline)